Conversely, compared to TET2/IDH1/2 mutations, which are generally present as initiating mutations in AML and have a relatively stable presence, WT1 mutations are considered to be secondary events in AML and are much less stable [40]. The gene discussed is IDH1; the disease is acute myeloid leukemia.